Humira: ad spend in the U.S. 2021

In 2021, AbbVie's advertising spending on Humira in the United States decreased to 236 million U.S. dollars. In the previous year, the pharmaceutical company invested 478 million U.S. dollars in measured media advertising of the drug.

AbbVie's advertising spending on Humira in the United States from 2014 to 2021 (in million U.S. dollars)

Characteristic	Spending in million U.S. dollars
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-

Download

Source

Show detailed source information?

Already a member?

Sources

Use Ask Statista Research Service

Release date

July 2022

More information

Region

United States

Survey time period

2014 to 2021

Special properties

measured media only

Supplementary notes

Measured media is based on spending in 19 media: consumer magazines, Sunday magazines, local magazines, business-to-business magazines, local newspapers, national newspapers, free-standing inserts, broadcast network TV, broadcast spot TV, national syndicated TV, network cable TV, network radio, national spot radio, local radio, Spanish-language media (magazines, newspapers, TV networks), outdoor and internet (display advertising; excludes paid search, video and other forms of internet advertising).
The figures do not include unmeasured spending, such as direct marketing, promotion, internet paid search, social media and other forms of spending not included in the 19 measured media.

Citation formats